Medytox Announces Special Meeting of Its Stockholders to Be Held October 28, 2015

Medytox Announces Special Meeting of Its Stockholders to Be Held October 28, 2015

WEST PALM BEACH, FL — (Marketwired) — 09/24/15 — Medytox Solutions, Inc. (MMMS) ("Medytox") today announced that the registration statement on Form S-4 filed by CollabRx, Inc. (CLRX) ("CollabRx"), and the definitive joint proxy statement/prospectus contained therein, regarding Medytox–s proposed merger with CollabRx, has been declared effective by the Securities and Exchange Commission (the "SEC").Medytox will hold a special meeting of its stockholders on Wedne

Dan McGraw Joins SRS Leadership Team as Senior Vice President of Sales

Dan McGraw Joins SRS Leadership Team as Senior Vice President of Sales

MONTVALE, NJ — (Marketwired) — 08/17/15 — SRSsoft, the leader in productivity-enhancing EHR and HIT solutions for specialists, today announced the appointment of Daniel McGraw as the company–s new Senior Vice President of Sales. As SRS enters its next phase of growth, Mr. McGraw–s sales leadership and change management expertise will have a defining impact on the company–s market strategy."SRS is experiencing an exciting period of innovation," says CEO Scott Ciccarelli. "Da

4medica CEO to Deliver Message on New Ways for Labs to Provide Lab Test Data to Payers to Win Network Status at the 20th Annual Executive War College 2015

4medica CEO to Deliver Message on New Ways for Labs to Provide Lab Test Data to Payers to Win Network Status at the 20th Annual Executive War College 2015

LOS ANGELES, CA — (Marketwired) — 04/29/15 — , provider of the industry–s leading cloud clinical integration platform and solutions, today announced founder and CEO Oleg Bess, M.D., will speak at the 20th Annual Executive War College Conference, taking place May 05-06, 2015 at the Sheraton Hotel in New Orleans.Dr. Bess will present a Master Class, "New Ways for Labs to Provide Lab Test Data to Payers to Win Network Status," at 8:00 a.m. on Tuesday, May 5. The presentation will exa

1 2 3 9